Co-locates Philips Intellispace Genomics R&D team within New York
Medical College to advance solution for Precision Medicine for Cancer
Treatment
Company Website:
http://www.usa.philips.com/
CAMBRIDGE, Mass. -- (Business Wire)
Royal
Philips (NYSE:PHG, AEX:PHIA) today announced that it is co-locating
researchers from its Philips Intellispace Genomics team with New
York Medical College (NYMC), one of the oldest and largest health
sciences universities in the country, and a long-standing collaborator
in the creation of the Philips
IntelliSpace solution for oncology genomics. Located in Westchester,
New York, the Philips team will be sharing space at the NYMC new
biotechnology incubator, BioInc@NYMC and working on collaborative
computational genomics of large data sets. This not only supports
Philips work in personalized cancer care, but it also builds on Philips
Research North America’s efforts to cross-pollinate with leading
academic institutions, helping to develop innovations that can address
society’s most pressing healthcare challenges and deliver on the
company’s vision of improving the lives of three billion people by 2025.
Philips’ IntelliSpace Genomics is a configurable, scalable and secure
healthcare informatics solution across hospitals for delivering
real-time, actionable diagnostic information to physicians and
specialists for therapy planning at the point of care. Philips
IntelliSpace Genomics’ collaborative solution enables physicians to
answer key clinical questions by leveraging the best clinical expertise
and algorithmic power in integrated workflows. It seamlessly brings data
from multiple sources, including raw sequencing data, up-to-date in
silico genomic databases, clinical data and knowledge databases,
longitudinal patient records, medical images and pathology data, among
others.
“Bringing on Phillips Healthcare Research as the anchor tenant at
BioInc@NYMC is a true game changer – for the college, Westchester County
and beyond. The positioning of nine innovative companies alongside such
a notable name in healthcare research will add to the already impressive
track record of our start-ups and the medical solutions they develop,”
said Randi D. Schwartz, M.B.A., Director of BioInc@NYMC and Associate
Dean for academic administration.
"BioInc@NYMC is a thriving member of both the Westchester and the
greater New York innovation ecosystem. We are excited to announce
Phillips Healthcare Research as our biotech/high-tech incubator's new
anchor tenant. The computational genomics collaboration between NYMC and
Philips promises both research and economic benefits. Philips Healthcare
Research and BioInc@NYMC's other clients are working every day to
develop novel technologies and healthcare solutions," said D. Douglas
Miller, M.D., C.M., M.B.A., Dean of the School of Medicine at New York
Medical College, Vice-Provost for Biomedical Affairs and Chief
Scientific Officer of BioInc@NYMC.
Working from space on the NYMC campus allows Philips to collaborate more
closely with its innovation partners at the College and their three
affiliated teaching hospitals on the Valhalla, New York campus of Westchester
Medical Center Health Network (WMCHealth). WMCHealth
has also launched a new precision medicine initiative for personalized
cancer treatment, which will leverage Philips’ IntelliSpace Genomics
solution as one of the first partners to integrate large-scale genomic
analysis with extensive patient clinical data.
“In order to create technologies that can have a meaningful impact on
human health and enable us to focus on building a healthy society, we
need to work closely with leading healthcare institutions to co-create
outcome-based solutions,” said Hans-Aloys Wischmann, Head of Philips
Research Americas. “No single company will be able to create the
solutions needed, it will take collaborative efforts, and we believe
that working with academic institutions like New York Medical College
will provide tremendous opportunities to shape a totally new approach to
the delivery of healthcare.”
About Royal Philips
Royal Philips (NYSE:PHG, AEX:PHIA) is a leading health technology
company focused on improving people's health and enabling better
outcomes across the health continuum from healthy living and prevention,
to diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, image-guided therapy, patient monitoring and health
informatics, as well as in consumer health and home care. Philips'
health technology portfolio generated 2015 sales of EUR 16.8 billion and
employs approximately 70,000 employees with sales and services in more
than 100 countries. News about Philips can be found at www.philips.com/newscenter.
About New York Medical College
Founded in 1860, NYMC is one of the oldest and largest health sciences
colleges in the country with more than 1,400 students, 1,300 residents
and clinical fellows, nearly 3,000 faculty members, and 16,000 living
alumni. The College, which joined the Touro College and University
System in 2011, is located in Westchester County, New York, and offers
advanced degrees from the School of Medicine, the Graduate School of
Basic Medical Sciences, and the School of Health Sciences and Practice.
With a network of affiliated hospitals that includes large urban medical
centers, small suburban clinics and high-tech regional tertiary care
facilities, NYMC provides a wide variety of clinical training
opportunities throughout the tri-state region for medical students,
residents, and other health providers.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161206005818/en/
Contacts:
Philips North America
Silvie Casanova, 978-657-7467
silvie.casanova@philips.com
Source: Royal Philips
© 2024 Canjex Publishing Ltd. All rights reserved.